Purakkattle Biju - Concepedia

Author

Purakkattle Biju

Merck & Co., Inc., Rahway, NJ, USA (United States)

Also Known As

Biju Purakkattle, P. J. Biju, P. John Biju, P.John Biju, Purakkattle Biju, Purakkattle J. Biju

Publications

359

Citations

H-Index

Concepts

All Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)United States Pharmacopeial Convention

About

Purakkattle Biju is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in drug discovery, medicine, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	255
2	Biochemistry	6	6	220
3	Natural Sciences	2	2	128
4	Engineering	1	1	11
5	Biomolecular Engineering	1	1	14

Purakkattle Biju

Publications

292

Citations

H-Index

Page 1

	Year	Citations
Discovery of 2-Hydroxy-<i>N</i>,<i>N</i>-dimethyl-3-{2-[[(<i>R</i>)-1-(5- methylfuran-2-yl)propyl]amino]-3,4-dioxocyclobut-1-enylamino}benzamide (SCH 527123): A Potent, Orally Bioavailable CXCR2/CXCR1 Receptor Antagonist Michael P. Dwyer, Younong Yu, Jianping Chao, Journal of Medicinal Chemistry Pharmaceutical ScienceDrug TargetImmunologyPharmacotherapyLead Cyclobutenedione 3	2006	113
C(4)-alkyl substituted furanyl cyclobutenediones as potent, orally bioavailable CXCR2 and CXCR1 receptor antagonists Jianhua Chao, Arthur G. Taveras, Jianping Chao, Bioorganic & Medicinal Chemistry Letters Bioavailable Cxcr2Pharmacological StudyBiochemistryFuranyl CyclobutenedionesMedicine	2007	43
3,4-Diamino-2,5-thiadiazole-1-oxides as potent CXCR2/CXCR1 antagonists Purakkattle Biju, Arthur G. Taveras, Younong Yu, Bioorganic & Medicinal Chemistry Letters MedicineMechanism Of ActionPharmacological AgentPharmacotherapyPharmacology	2007	23
Steroidal C-21 mercapto derivatives as dissociated steroids: Discovery of an inhaled dissociated steroid Purakkattle Biju, Kevin D. McCormick, Robert Aslanian, Bioorganic & Medicinal Chemistry Letters Dissociated SteroidsPharmaceutical ScienceBiochemistryMedicinePulmonary Pharmacology	2011	19
Synthesis and structure–activity relationships of heteroaryl substituted-3,4-diamino-3-cyclobut-3-ene-1,2-dione CXCR2/CXCR1 receptor antagonists Younong Yu, Michael P. Dwyer, Jianping Chao, Bioorganic & Medicinal Chemistry Letters Molecular PharmacologyBiochemistryMedicineMechanism Of ActionReceptor (Biochemistry)	2008	17
New Methodology for the Synthesis of <b>α,α</b>-difluoroketones Purakkattle Biju Synthetic Communications Weinreb AmidesBiochemistryNatural SciencesFluorous SynthesisOrganic Chemistry	2008	15
Fluoroalkyl α side chain containing 3,4-diamino-cyclobutenediones as potent and orally bioavailable CXCR2–CXCR1 dual antagonists Purakkattle Biju, Arthur G. Taveras, Michael P. Dwyer, Bioorganic & Medicinal Chemistry Letters Molecular PharmacologyMedicinal ChemistryPharmaceutical ScienceMedicinePharmacological Agent	2009	14
3,4-Diamino-1,2,5-thiadiazole as potent and selective CXCR2 antagonists Purakkattle Biju, Arthur G. Taveras, Younong Yu, Bioorganic & Medicinal Chemistry Letters Molecular PharmacologySelective Cxcr2 AntagonistsMedicineMechanism Of ActionPharmacological Agent	2009	13
Discovery of aminoquinazoline derivatives as human A2A adenosine receptor antagonists Robert Aslanian, Gioconda Gallo, Tanweer A. Khan, Bioorganic & Medicinal Chemistry Letters Molecular PharmacologyBiochemistryFunctional SelectivityMedicineMechanism Of Action	2015	13
Aromatics to polyquinanes: A general method for the construction of tricyclo[6.3.0.04,8]-and tricyclo[6.3.0.02,6]undecanes Purakkattle Biju, G. S. R. Subba Rao Tetrahedron Letters Chemical EngineeringEngineeringHeterocyclicOrganic ChemistryChemistry	1999	11

Page 1